Papillary thyroid carcinoma with prominent myofibroblastic stromal component: clinicopathologic, immunohistochemical and next-generation sequencing study of seven cases

. 2020 Sep ; 33 (9) : 1702-1711. [epub] 20200414

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid32291398

Papillary thyroid carcinoma with desmoid-type fibromatosis or nodular fasciitis-like stroma is an extremely unusual and poorly understood subtype of papillary thyroid cancer. Although prior studies have demonstrated alterations in the Wnt/β-catenin signaling pathway in some of these tumors, controversy still exists regarding the nature of the stromal spindle component. We have studied seven cases of papillary thyroid carcinoma with prominent myofibroblastic stroma, including six men and one woman aged 20-65 years (mean age = 44). All cases displayed areas consistent with conventional papillary thyroid carcinoma embedded in abundant myofibroblastic-like stroma. The myofibroblastic stroma in six cases resembled desmoid-type fibromatosis and in one case it more closely resembled nodular fasciitis. By immunohistochemical staining, the stromal spindle component showed positivity for SMA and low MIB1 proliferation index in all cases, and there was at least patchy strong nuclear positivity for beta-catenin in six/seven cases. Stains for cytokeratin AE1/AE3 and PAX8 were positive in the epithelial elements but negative in the stromal component. Next-generation sequencing was performed on six of seven cases. CTNNB1 gene mutations were identified in six/seven cases. The epithelial component showed BRAF mutations in two cases and an NRAS mutation in one case. The case with fasciitis-like stroma was negative for beta-catenin by sequencing and immunostaining as well as negative for USP6 gene rearrangement. Our findings indicate that papillary thyroid carcinoma with prominent myofibroblastic stroma may represent more than one category of lesions.

Komentář v

PubMed

Zobrazit více v PubMed

Lloyd R, Osamura R, Kloppel G. WHO classification of tumors of endocrine organs. Lyon, France: IARC Press; 2017.

Michal M, Chlumska A, Fakan F. Papillary carcinoma of thyroid with exuberant nodular fasciitis-like stroma. Histopathology. 1992;21:577–9. PubMed

Chan JK, Carcangiu ML, Rosai J. Papillary carcinoma of thyroid with exuberant nodular fasciitis-like stroma. Report of three cases. Am J Clin Pathol. 1991;95:309–14. PubMed

Chan JK. Papillary carcinoma of thyroid: classical and variants. Histol Histopathol. 1990;5:241–57. PubMed

Mizukami Y, Nonomura A, Matsubara F, Michigishi T, Ohmura K, Hashimoto T. Papillary carcinoma of the thyroid gland with fibromatosis-like stroma. Histopathology. 1992;20:355–7. PubMed

Mizukami Y, Kurumaya H, Kitagawa T, Minato H, Nonomura A, Michigishi T, et al. Papillary carcinoma of the thyroid gland with fibromatosis-like stroma: a case report and review of the literature. Mod Pathol. 1995;8:366–70. PubMed

Naganuma H, Iwama N, Nakamura Y, Ohtani N, Ohtani H, Takaya K, et al. Papillary carcinoma of the thyroid gland forming a myofibroblastic nodular tumor: report of two cases and review of the literature. Pathol Int. 2002;52:54–8. PubMed

Wu Z, Chu X, Fan S, Meng X, Xu C. Papillary thyroid carcinoma with fibromatosis-like stroma: a case report and review of the literature. Oncol Lett. 2013;5:215–7. PubMed

Inaba M, Umemura S, Satoh H, Ichikawa Y, Abe Y, Kirokawa K, et al. Papillary thyroid carcinoma with fibromatosis-like stroma: a report of two cases. Endocr Pathol. 2002;13:219–25. PubMed

Toti P, Tanganelli P, Schürfeld K, Stumpo M, Barbagli L, Vatti R, et al. Scarring in papillary carcinoma of the thyroid: report of two new cases with exuberant nodular fasciitis-like stroma. Histopathology. 1999;35:418–22. PubMed

Terayama K, Toda S, Yonemitsu N, Koike N, Sugihara H. Papillary carcinoma of the thyroid with exuberant nodular fasciitis-like stroma. Virchows Arch. 1997;431:291–5. PubMed

Roth EM, Barrows CE, Nishino M, Sacks B, Hasselgren PO, James BC. Papillary thyroid cancer with extrathyroidal extension of desmoid-type fibromatosis. A case report of an aggressive presentation of an uncommon pathologic entity. Int J Surg Case Rep. 2019;63:5–9. PubMed PMC

Rebecchini C, Nobile A, Piana S, Sarro R, Bisig B, Gerasimos SP, et al. Papillary thyroid carcinoma with nodular fasciitis-like stroma and β-catenin mutations should be renamed papillary thyroid carcinoma with desmoid-type fibromatosis. Mod Pathol. 2017;30:236–45. PubMed

Tajiri K, Hirokawa M, Suzuki A, Takada N, Ota H, Oshita M, et al. Can Ultrasound alone predict papillary thyroid carcinoma with desmoid-type fibromatosis? A retrospective analysis of 13 cases, focusing on the stromal area. Ultrasound Int Open. 2018;4:E39–44. PubMed PMC

Takada N, Mussazhanova Z, Hirokawa M, Nakashima M, Miyauchi A. Immunohistochemical and molecular analyses focusing on mesenchymal cells in papillary thyroid carcinoma with desmoid-type fibromatosis. Pathobiology. 2018;85:300–3. PubMed

Takada N, Hirokawa M, Ito M, Suzuki A, Higuchi M, Kuma S, et al. Papillary thyroid carcinoma with desmoid-type fibromatosis: a clinical, pathological, and immunohistochemical study of 14 cases. Endocr J. 2017;64:1017–23. PubMed

Zhou L, Shi L, Jiang Z, Xie L. Papillary thyroid carcinoma with nodular fasciitis-like stroma and B-catenin gene mutations: report of a recurrent case. Int J Clin Exp Pathol. 2018;11:2879–83. PubMed PMC

Wong SBJ, Nga ME, Michal M, Vanecek T, Seet JE, Petersson F. SOX11 expression in a case of papillary thyroid carcinoma with fibromatosis/fasciitis-like stroma containing BRAF c.1799_1801delTGA and CTNNB1 c.133T>C mutations. Virchows Arch. 2019;475:519–25. PubMed

Skalova A, Vanecek T, Martinek P, Weinreb I, Stevens TM, Simpson RHW, et al. Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation; report of 10 cases. Am J Surg Path. 2018;42:234–46. PubMed

Svajdler M, Michal M, Martinek P, Ptakova N, Kinkor Z, Szepe P, et al. Fibro-osseous pseudotumor of digits and myositis ossificans show consistent COL1A1-USP6 rearrangement: a clinicopathological and genetic study of 27 cases. Hum Pathol. 2019;88:39–47. PubMed

Cho JG, Byeon HK, Oh KH, eBaek SK, Kwon SY, Jung KY, et al. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis. Eur Arch Otorhinolaryngol. 2018;275:2355–6231. PubMed

Tajima S, Takanashi Y, Koda K. Squamous cell carcinoma of the lung with highly proliferating fibromatosis-like stroma: a rare phenomenon. Int J Clin Exp Pathol. 2015;8:5870–6. PubMed PMC

Švajdler M, Michal M, Dubinsky P, Svajdler P, Ondic O, Michal M. Endometrial endometrioid carcinoma with large cystic growth configuration and deceptive pattern of invasion associated with abundant nodular fasciitis-like stroma: a unique hitherto unreported histology in endometrioid carcinoma. Adv Anat Pathol. 2016;23:381–4. PubMed

Brandwein-Gensler MS, Wang BY, Urken ML. Spindle cell transformation of papillary carcinoma: an aggressive entity distinct from anaplastic thyroid carcinoma. Arch Pathol Lab Med. 2004;128:87–9. PubMed

Kim SW, Oh YL, Choi JY, Lee JI, Chung JH, Kim JS. Postoperative spindle cell nodule after thyroidectomy: a case mimicking recurrence with anaplastic transformation of thyroid cancer. Head Neck. 2013;35:E13–7. PubMed

Thompson LDR, Wei C, Rooper LM, Lau SK. Thyroid gland solitary fibrous tumor: report of 3 cases and a comprehensive review of the literature. Head Neck Pathol. 2019;13:597–605. PubMed PMC

Papi G, Corrado S, LiVolsi VA. Primary spindle cell lesions of the thyroid gland; an overview. Am J Clin Pathol. 2006;125:S95–123. PubMed

Ragazzi M, Ciarrocchi A, Sancisi V, Gandolfi G, Bisagni A, Piana S. Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int J Endocrinol. 2014;2014:790834. PubMed PMC

Yang YJ, LiVolsi VA, Khurana KK. Papillary thyroid carcinoma with nodular fasciitis-like stroma. Pitfalls in fine-needle aspiration cytology. Arch Pathol Lab Med. 1999;123:838–41. PubMed

Misemer BS, Skubitz AP, Carlos Manivel J, Schmechel SC, Cheng EY, Henriksen JC, et al. Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. Cancer Med. 2014;3:81–90. PubMed

Basu S, Nair N, Shet T, Borges AM. Papillary thyroid carcinoma with exuberant nodular fasciitis-like stroma: treatment outcome and prognosis. J Laryngol Otol. 2006;120:338–42. PubMed

Gao C, Wang Y, Broaddus R, Sun L, Xue F, Zhang W. Exon 3 mutations of CTNNB1 drive tumorigenesis: a review. Oncotarget. 2017;9:5492–508. PubMed PMC

Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I, et al. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol. 2012;25:1551–8. PubMed

Lam AKY, Saremi N. Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer. Endocr Relat Cancer. 2017;24:R109–21. PubMed

Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173:1518–27. PubMed PMC

Patel NR, Chrisinger JSA, Demicco EG, Sarabia SF, Reuther J, Kumar E, et al. USP6 activation in nodular fasciitis by promoter-swapping gene fusions. Mod Pathol. 2017;30:1577–88. PubMed

Erber R, Agaimy A. Misses and near misses in diagnosing nodular fasciitis and morphologically related reactive myofibroblastic proliferations: experience of a referral center with emphasis on frequency of USP6 gene rearrangements. Virchows Arch. 2018;473:351–60. PubMed

Shin C, Low I, Ng D, Oei P, Miles C, Symmans P. USP6 gene rearrangement in nodular fasciitis and histological mimics. Histopathology. 2016;69:784–91. PubMed

Zou M, Baitei EY, Alzahrani AS, BinHumaid FS, Alkhafaji D, Al-Rijjal RA, et al. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Thyroid. 2014;24:1256–66. PubMed PMC

Tarabichi M, Antoniou A, Le Pennec S, Gacquer D, de Saint Aubain N, Craciun L, et al. Distinctive desmoplastic 3D morphology associated with BRAFV600E in papillary thyroid cancers. J Clin Endocrinol Metab. 2018;103:1102–11. PubMed

Jang MA, Lee ST, Oh YL, Kim SW, Chung JH, Ki CS, et al. Identification of a rare 3 bp BRAF gene deletion in a thyroid nodule by mutant enrichment with 3′-modified oligonucleotides polymerase chain reaction. Ann Lab Med. 2012;32:238–41. PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...